Dr. Alwine is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
77 Manor Ave
Ste 100
Downingtown, PA 19335Phone+1 610-269-9570Fax+1 610-269-3568
Education & Training
Philadelphia College of Osteopathic MedicineClass of 1975
Certifications & Licensure
PA State License 1976 - 2026
Clinical Trials
- A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2014 Apr 01
- Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Publications & Presentations
PubMed
- 13 citationsLong-term tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities.John H. Peniston, Morris S. Gold, Matthew S. Wieman, Lawrence K Alwine
Clinical Interventions in Aging. 2012-11-20 - 9 citationsAn Open-Label, Long-Term Safety and Tolerability Trial of Diclofenac Sodium 1% Gel in Patients with Knee OsteoarthritisJohn H. Peniston, Morris S. Gold, Lawrence K Alwine
The Physician and Sportsmedicine. 2011-09-01 - 4 citationsTolerability of diclofenac sodium 1% gel with concomitant medications known to interact with diclofenacJohn H. Peniston, Morris S. Gold, Matthew S. Wieman, Lawrence K Alwine
Therapeutics and Clinical Risk Management. 2013-04-16
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
